1h Free Analyst Time
The oncology molecular diagnostics market is forecasted to grow by USD 3.95 billion during 2023-2028, accelerating at a CAGR of 13.64% during the forecast period. The report on the oncology molecular diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of cancer worldwide, growing geriatric population, and increase in adoption of microarrays in genomics and proteomics.
The oncology molecular diagnostics market is segmented as below:
By Product
- Reagents and kits
- Instruments
By Type
- Breast cancer
- Colorectal cancer
- Prostate cancer
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the oncology molecular diagnostics market covers the following areas:
- Oncology molecular diagnostics market sizing
- Oncology molecular diagnostics market forecast
- Oncology molecular diagnostics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global oncology molecular diagnostics market: Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Biocartis NV, bioMerieux SA, Danaher Corp., DiaSorin SpA, Exact Sciences Corp., F. Hoffmann La Roche Ltd., Grifols SA, Hologic Inc., HTG Molecular Diagnostics Inc., Illumina Inc., MDXHEALTH SA, Myriad Genetics Inc., QIAGEN NV, QuidelOrtho Corp., Siemens Healthineers AG, Sysmex Corp., TBG Diagnostics Ltd., Thermo Fisher Scientific Inc., and Veracyte Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is integration of next-generation sequencing in oncology molecular diagnostics."
According to the report, one of the major drivers for this market is the increasing prevalence of cancer worldwide.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Agilent Technologies Inc.
- Becton Dickinson and Co.
- Biocartis NV
- bioMerieux SA
- Danaher Corp.
- DiaSorin SpA
- Exact Sciences Corp.
- F. Hoffmann La Roche Ltd.
- Grifols SA
- Hologic Inc.
- HTG Molecular Diagnostics Inc.
- Illumina Inc.
- MDXHEALTH SA
- Myriad Genetics Inc.
- QIAGEN NV
- QuidelOrtho Corp.
- Siemens Healthineers AG
- Sysmex Corp.
- TBG Diagnostics Ltd.
- Thermo Fisher Scientific Inc.
- Veracyte Inc.
